Dr. Burzynski is a physician and investigator recognized for pioneering the use of biologically active peptides for cancer treatment. He holds both MD and PhD degrees and has extensive experience in targeted agents, immunotherapy, and phenylbutyrate for cancer. His research focuses on antineoplastons, investigational agents derived from his early work on naturally occurring human peptides.
Czy to Twój profil? Zarejestruj się, aby zarządzać swoim profilem, uzupełnić informacje, publikować artykuły i otrzymywać zapytania od klientów.
Przejmij ten profil →